RE:Covid opp - Covalon a global leader in infection prevention Hoping to see Cov trade in line with the US trading today - $2.60 CDN at the close.
bigreturn11 wrote: I spoke to investor relations. Looks like the real deal. This product is nothing new, but the company is off the radar obviously as nobody suspected that they could hold IP to an important issue. Covalon specializes in infection control and this product falls in line with the IP that the currently holds. Of course they would love to be discovered by large company to license their product or distrubutors that have aa global reach. A corporation that can partnered with on the IP and run with it.
This product is currently focussed on medical sectors as I understand, however has applications for industrial, urban, commercial business. Airports, arlines, hotels, cruise lines, casinos, sporting events, concerts, your business, your home, grocery stores, retirement complex. Basically all the sectors that have been hit hard or are at risk of covid could use this product as a defense mechanism. When busiensses re-open, strict policies will need to be in place for infection control/mitigation and a product that prevents many lethal viruses from surviving on the surface over an extended period makes me think that the time is now for Covalon.
The product is ready for market within a couple weeks as I understand. Meaning it could be scaled and sold nearly immediately through our period of isolation an protection.
iiroc is cracking down on any company NR's that include Covid19 claims to ensure that there is nothing misleading. It just so happens to be that infeciton control is 100% of Covalon's focus and this is not an outlandish claim like others are making on the markets.
Hopefully companies like W.W. Grainger or J&J can license their IP and use their global reach to launch this product on a mass scale. Until we hear further updates, congrats to all other shareholders for being part of an outsatnding company.